Home
Conditions
Carcinoma

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,811 public trials 2,094 recruiting studies

Refine in advanced search Browse all conditions

Carcinoma trial results

Enrolling by Invitation

Prognostic Value of TIL in Nasopharyngeal Carcinoma

NCT06763640

Conditions: Carcinoma, Head and Neck Neoplasms, Nasopharyngeal Carcinoma, +12 more
Locations: Jiangxi Cancer Hospital Nanchang, Jiangxi, China

View Trial Details

Enrolling by Invitation

Plasma Exosomes Reveal the Efficacy of Targeted Therapy in Patients With EGFR Mutation in Lung Adenocarcinoma

NCT06730477

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +9 more
Locations: Union hospital, Tongji Medical college, Huazhong University of Science and Technology Wuhan, Hubei, China

View Trial Details

Enrolling by Invitation

Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China

NCT06712017

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
Locations: The Second Affiliated Hospital of Guangzhou Medical University Guangzhou, Guangdong, China

The First Affiliated Hospital of Jinan University Jinan, Guangdong, China

Xi'An International Medical Center Hospital Xi’an, Guangxi, China

No.1 Affiliated Hospital of Xian Jiaotong University Xi’an, Shanxi, China

View Trial Details

Enrolling by Invitation

A Multicenter Prospective Observational Study of Computer-aided Risk Perception and Prognosis Prediction in the Whole Process of Laparoscopic Hepatobiliary and Pancreatic Surgery

NCT06647264

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
Locations: Department of hepatobiliary surgery, Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Enrolling by Invitation

Liver Transplant for Stable, Advanced Intrahepatic Cholangiocarcinoma

NCT04195503

Conditions: Adenocarcinoma, Carcinoma, Cholangiocarcinoma, +4 more
Locations: University Health Network Toronto, Ontario, Canada

View Trial Details

Enrolling by Invitation

Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular Carcinoma

NCT06540508

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Cancer Hospital, Chinese Academy of Medical Sciences Beijing, Beijing Municipality, China

View Trial Details

Enrolling by Invitation

Neoadjuvant Chemoradiotherapy Followed by Sequential Immunotherapy for Thoracic Esophageal Squamous Cell Carcinoma

NCT06303583

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: Zhejiang Cancer Hospital Hangzhou, Zhejiang, China

View Trial Details

Enrolling by Invitation

Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma

NCT06048926

Conditions: Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +12 more
Locations: The First Affiliated Hospital of Nanjing Medical University Nanjing, China

View Trial Details

Enrolling by Invitation

An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

NCT01511393

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Medullary, +18 more
Locations: United BioSource, LLC Morgantown, West Virginia, United States

View Trial Details

Enrolling by Invitation

Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients

NCT05171335

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations: Houston Methodist Research Institute Houston, Texas, United States

View Trial Details

Carcinoma

Carcinoma trial results

Related conditions